BR9813775A - Use of a compound, process for the treatment of a vascular headache condition, and, pharmaceutical composition suitable for use in the treatment of a vascular headache condition. - Google Patents

Use of a compound, process for the treatment of a vascular headache condition, and, pharmaceutical composition suitable for use in the treatment of a vascular headache condition.

Info

Publication number
BR9813775A
BR9813775A BR9813775-1A BR9813775A BR9813775A BR 9813775 A BR9813775 A BR 9813775A BR 9813775 A BR9813775 A BR 9813775A BR 9813775 A BR9813775 A BR 9813775A
Authority
BR
Brazil
Prior art keywords
treatment
vascular headache
compound
condition
headache condition
Prior art date
Application number
BR9813775-1A
Other languages
Portuguese (pt)
Inventor
Carl-Johan Dalsgaard
Arne Eek
Lennart Waldenlind
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BR9813775A publication Critical patent/BR9813775A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"USO DE UM COMPOSTO, PROCESSO PARA O TRATAMENTO DE UMA CONDIçãO DE CEFALéIA VASCULAR, E, COMPOSIçãO FARMACêUTICA ADEQUADA PARA USO NO TRATAMENTO DE UMA CONDIçãO DE CEFALéIA VASCULAR" A presente invenção apresenta um novo uso de um composto de fórmula (I) em que R¹ representa alquila C~ 3-5~; e R² e R³ independentemente representam alquila C~ 1-3~; ou um seu sal farmaceuticamente aceitável; para a fabricação de um medicamento para o tratamento de uma condição de cefaléia vascular, particularmente a enxaqueca."USE OF A COMPOUND, PROCESS FOR THE TREATMENT OF A CONDITION OF VASCULAR HEADACHE, AND, PHARMACEUTICAL COMPOSITION SUITABLE FOR USE IN THE TREATMENT OF A CONDITION OF VASCULAR HEADACHE" The present invention presents a new use of a compound of formula (I) in which R¹ represents C ~ 3-5 ~ alkyl; and R² and R³ independently represent C ~ 1-3 ~ alkyl; or a pharmaceutically acceptable salt thereof; for the manufacture of a medicine for the treatment of a vascular headache condition, particularly migraine.

BR9813775-1A 1997-12-19 1998-12-14 Use of a compound, process for the treatment of a vascular headache condition, and, pharmaceutical composition suitable for use in the treatment of a vascular headache condition. BR9813775A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704770A SE9704770D0 (en) 1997-12-19 1997-12-19 New use
PCT/SE1998/002299 WO1999032103A1 (en) 1997-12-19 1998-12-14 New use of local anaesthetics against vascular headaches

Publications (1)

Publication Number Publication Date
BR9813775A true BR9813775A (en) 2000-10-10

Family

ID=20409476

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813775-1A BR9813775A (en) 1997-12-19 1998-12-14 Use of a compound, process for the treatment of a vascular headache condition, and, pharmaceutical composition suitable for use in the treatment of a vascular headache condition.

Country Status (18)

Country Link
EP (1) EP1047412A1 (en)
JP (1) JP2001526217A (en)
KR (1) KR20010024768A (en)
CN (1) CN1282241A (en)
AU (1) AU1898199A (en)
BR (1) BR9813775A (en)
CA (1) CA2314452A1 (en)
EE (1) EE200000394A (en)
HU (1) HUP0100599A3 (en)
ID (1) ID26703A (en)
IL (1) IL136518A0 (en)
IS (1) IS5534A (en)
NO (1) NO20003138L (en)
PL (1) PL341283A1 (en)
SE (1) SE9704770D0 (en)
SK (1) SK7832000A3 (en)
TR (1) TR200001926T2 (en)
WO (1) WO1999032103A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
AU2862200A (en) 1999-01-27 2000-08-18 Bruce H. Levin Compositions, kits, apparatus, and methods for inhibiting cerebral neurovasculardisorders and muscular headaches
WO2001043733A2 (en) * 1999-12-15 2001-06-21 Levin Bruce H Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
RS65360B1 (en) 2014-03-21 2024-04-30 Teva Pharmaceuticals Int Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
MX2018003713A (en) * 2015-09-24 2018-08-15 Teva Pharmaceuticals Int Gmbh Preventing, treating, and reducing (persistent) post-traumatic headache.
WO2018055574A1 (en) 2016-09-23 2018-03-29 Teva Pharmaceuticals International Gmbh Treating refractory migraine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH380746A (en) * 1958-11-06 1964-08-15 Ciba Geigy Process for the preparation of new secondary amines
US3988475A (en) * 1974-02-05 1976-10-26 Istituto Luso Farmaco D'italia S.R.L. Phenoxyalkylamines
AR004691A1 (en) * 1995-10-27 1999-03-10 Astrazeneca Ab NEW DERIVATIVES OF [3-ALCOXI-PENOXI -) - ETIL] -DIALKYLAMINE, A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM, THEIR USE AS LOCAL ANESTHETICS AND A PROCEDURE FOR THEIR PREPARATION

Also Published As

Publication number Publication date
NO20003138D0 (en) 2000-06-16
ID26703A (en) 2001-02-01
HUP0100599A2 (en) 2002-02-28
HUP0100599A3 (en) 2002-04-29
PL341283A1 (en) 2001-04-09
WO1999032103A1 (en) 1999-07-01
EP1047412A1 (en) 2000-11-02
TR200001926T2 (en) 2000-11-21
JP2001526217A (en) 2001-12-18
NO20003138L (en) 2000-08-18
AU1898199A (en) 1999-07-12
IS5534A (en) 2000-06-15
SK7832000A3 (en) 2001-02-12
SE9704770D0 (en) 1997-12-19
KR20010024768A (en) 2001-03-26
CN1282241A (en) 2001-01-31
IL136518A0 (en) 2001-06-14
EE200000394A (en) 2001-12-17
CA2314452A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
DE69426331D1 (en) MEDICINE FOR NERVOUS DISEASES
BR9808281A (en) Compounds, pharmaceutical compositions, process for treating proliferative diseases and / or disorders of the immune system and for preparing a compound, and, use of a compound
BRPI0411255A (en) compound, pharmaceutical composition, use of a compound, methods of treating a disorder of a patient, and process for the preparation of a compound
PT96145A (en) METHOD FOR PREPARING NEW AMINO ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR0111980A (en) Substituted amine, protected compound, methods for treating a patient having or preventing a patient from contracting a disease or condition, inhibiting beta-secretase activity, inhibiting cleavage of amyloid precursor protein (app), inhibiting Production of the beta amyloid peptide (a beta) in a cell, to inhibit beta0amyloid plaque production in an animal, and to treat or prevent a disease comprising beta-amyloid deposits in the brain, composition method for producing a beta-secretase complex , assembly, and use of substituted amine
BR9916282A (en) Compound, use of a compound and method of treatment
AR017164A1 (en) DERIVATIVES OF BENZAMIDINE, A PROCEDURE TO PREPARE THEM, THE USE OF THEM TO PREPARE A MEDICINAL PRODUCT, DRUGS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES OF BENZAMIDINE, AND A PROCEDURE TO OBTAIN THESE PHARMACEUTICAL PREPARATIONS.
PA8452201A1 (en) DERIVATIVES OF 9-DESOXO-9A-AZA-9A-HOMOERITROMICINA A C-4 "SUBSTITUTED.
BR9812364A (en) Compound, use thereof, pharmaceutical composition, amide derivative, and process for the preparation of an amide derivative or a pharmaceutically acceptable salt or in vivo cleavable ester thereof
BR9913592A (en) Compounds, compound preparation process, and pharmaceutical compositions
BR0010555A (en) Neuraminidase Inhibitors
ES2147230T3 (en) AMINO ACID DERIVATIVES, MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION.
PT94925A (en) METHOD FOR THE PREPARATION OF TIAZOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BRPI0016395B8 (en) adamantane derivatives
BR0210122A (en) Compound or a pharmaceutically acceptable salt thereof, method for treating or preventing a disease, use of the compound or salt thereof, and method for preparing the same
BR0212787A (en) Pharmaceutically acceptable compound or salt thereof, methods of treating or preventing disease and preparing a compound, use of a compound or salt, and pharmaceutical composition
BR0113590A (en) 7-oxopyridopyrimidines
BR9809234A (en) Compound, pharmaceutical composition, use of a compound, processes to treat or prevent diseases of the endocrinological system, to manufacture a drug, to prepare a compound and a set, and use of it.
DE69707372T2 (en) Use of a phosphoric acid diester for the manufacture of a medicament for the treatment of acne
BR9813775A (en) Use of a compound, process for the treatment of a vascular headache condition, and, pharmaceutical composition suitable for use in the treatment of a vascular headache condition.
DE69418744T2 (en) Use of prognane derivatives for the treatment of tumors
DE69419954D1 (en) Medicines for the treatment of skin diseases
AR005549A1 (en) DERIVATIVES OF 1-PIRAZOL-3-ILETIL-4-INDOL-3-ILPIPERIDINA, A PROCEDURE FOR PREPARING THEM, MEDICINES AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM, A PROCEDURE FOR PREPARING THE PHARMACEUTICAL PREPARATIONS AND USE OF THE SAME MEDICINAL PREPARATIONS FOR THE PREPARATIONS
BR9910185A (en) Use of a compound, and, process for the treatment of a patient suffering from, or at risk for, a mycobacterial disease
BR0211210A (en) Use of hydroxyl aryl or heteroaryl sulfonyl acids and their derivatives as agrecanase inhibitors

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A,5A,6A,7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.